{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:03:25Z","timestamp":1783191805798,"version":"3.54.6"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022572","name":"NIHR Sheffield Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Managing atherosclerotic cardiovascular disease in individuals with chronic lymphocytic leukaemia (CLL) is complicated by the uncertain antiplatelet effect exerted by Bruton\u2019s tyrosine kinase inhibitors. Concerns over increased bleeding risk with concurrent ibrutinib and dual antiplatelet therapy (DAPT) are balanced with the need to provide robust antiplatelet cover following percutaneous coronary intervention (PCI) and reduce the risk of stent-related complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>We describe a case of an 83-year-old patient with a background of stable CLL on ibrutinib. He was appropriately established on DAPT (clopidogrel and aspirin) prior to elective PCI. Post-procedure, the patient re-presented after six days with subacute stent thrombosis (SST). Platelet function tests demonstrated clopidogrel non-responder status, with high platelet reactivity to multiple agonists. He was switched to ticagrelor with excellent antiplatelet response and underwent repeat PCI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This case is the first description of SST in a patient on concurrent DAPT and ibrutinib. It highlights the need for appropriately robust P2Y12 inhibition despite bleeding concerns and ex vivo studies demonstrating some antiplatelet effect by ibrutinib. This case also highlights the role for platelet function testing to tailor antithrombotic regimens in complex and high-risk PCI patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytag352","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:44:02Z","timestamp":1779277442000},"source":"Crossref","is-referenced-by-count":1,"title":["Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4319-694X","authenticated-orcid":false,"given":"Omar","family":"Dirir","sequence":"first","affiliation":[{"name":"Cardiovascular Research Unit, Division of Clinical Medicine, The University of Sheffield , Sheffield S10 2RX ,","place":["UK"]},{"name":"NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield S10 2JF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7822-8852","authenticated-orcid":false,"given":"William A E","family":"Parker","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Unit, Division of Clinical Medicine, The University of Sheffield , Sheffield S10 2RX ,","place":["UK"]},{"name":"NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield S10 2JF ,","place":["UK"]},{"name":"South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield S5 7AU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6586-7612","authenticated-orcid":false,"given":"Hazel A","family":"Haley","sequence":"additional","affiliation":[{"name":"South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield S5 7AU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0028-3226","authenticated-orcid":false,"given":"Julian P","family":"Gunn","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Unit, Division of Clinical Medicine, The University of Sheffield , Sheffield S10 2RX ,","place":["UK"]},{"name":"NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield S10 2JF ,","place":["UK"]},{"name":"South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield S5 7AU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6677-6229","authenticated-orcid":false,"given":"Robert F","family":"Storey","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Unit, Division of Clinical Medicine, The University of Sheffield , Sheffield S10 2RX ,","place":["UK"]},{"name":"NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield S10 2JF ,","place":["UK"]},{"name":"South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield S5 7AU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2026052314563237000_ytag352-B1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1096\/fj.04-2748com","article-title":"Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI","volume":"19","author":"Penz","year":"2005","journal-title":"FASEB J"},{"key":"2026052314563237000_ytag352-B2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1055\/s-0039-1687877","article-title":"Btk inhibitors as first oral atherothrombosis-selective antiplatelet drugs?","volume":"119","author":"Busygina","year":"2019","journal-title":"Thromb Haemost"},{"key":"2026052314563237000_ytag352-B3","doi-asserted-by":"crossref","first-page":"C1231","DOI":"10.1152\/ajpcell.00040.2022","article-title":"Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology","volume":"323","author":"Zheng","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026052314563237000_ytag352-B4","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3324\/haematol.2015.126672","article-title":"Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib","volume":"100","author":"Lipsky","year":"2015","journal-title":"Haematologica"},{"key":"2026052314563237000_ytag352-B5","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2017-09-808808","article-title":"Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans","volume":"131","author":"Busygina","year":"2018","journal-title":"Blood"},{"key":"2026052314563237000_ytag352-B6","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.jacc.2011.11.068","article-title":"Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study","volume":"59","author":"Price","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026052314563237000_ytag352-B7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCGENETICS.110.958561","article-title":"First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET\/OFFSET and RESPOND genotype studies","volume":"3","author":"Tantry","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"2026052314563237000_ytag352-B8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"2026052314563237000_ytag352-B9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bph.16256","article-title":"The role of platelet P2Y(12) receptors in inflammation","volume":"181","author":"Parker","year":"2024","journal-title":"Br J Pharmacol"},{"key":"2026052314563237000_ytag352-B10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/CIRCULATIONAHA.118.034790","article-title":"Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease","volume":"138","author":"Orme","year":"2018","journal-title":"Circulation"},{"key":"2026052314563237000_ytag352-B11","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.jcin.2024.08.027","article-title":"International consensus statement on platelet function and genetic testing in percutaneous coronary intervention: 2024 update","volume":"17","author":"Angiolillo","year":"2024","journal-title":"Cardiovascular Interventions"},{"key":"2026052314563237000_ytag352-B12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4244\/EIJ-D-20-00361","article-title":"Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-ultimaster registry","volume":"16","author":"Mohamed","year":"2020","journal-title":"EuroIntervention"},{"key":"2026052314563237000_ytag352-B13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.123.067767","article-title":"Antiplatelet therapy after PCI: the art and science of De-escalation","volume":"149","author":"Storey","year":"2024","journal-title":"Circulation"},{"key":"2026052314563237000_ytag352-B14","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/bloodadvances.2017011999","article-title":"Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib","volume":"1","author":"Bye","year":"2017","journal-title":"Blood Adv"},{"key":"2026052314563237000_ytag352-B15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytag352\/68364877\/ytag352.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/5\/ytag352\/68364877\/ytag352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/5\/ytag352\/68364877\/ytag352.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T18:56:37Z","timestamp":1779562597000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytag352\/8690356"}},"subtitle":[],"editor":[{"given":"Grigoris","family":"Karamasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Yaser","family":"Alahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Mashiul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Piera","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytag352","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,30]]},"article-number":"ytag352"}}